Cargando…
Personalized therapy: CNS HGNET-BCOR responsiveness to arsenic trioxide combined with radiotherapy
High-grade neuroepithelial tumor of the central nervous system with BCOR alteration (HGNET-BCOR) is a rare, highly malignant tumor. At the time of this publication, no standard protocol exists to treat this tumor entity. In this work, we tested the responsiveness of the primary culture PhKh1 derived...
Autores principales: | Paret, Claudia, Russo, Alexandra, Otto, Henrike, Mayer, Arnulf, Zahnreich, Sebastian, Wagner, Wolfgang, Samuel, David, Scharnhorst, David, Solomon, David A., Dhall, Girish, Wong, Kenneth, Bender, Hannah, Alt, Francesca, Wingerter, Arthur, Neu, Marie A., Beck, Olaf, Prawitt, Dirk, Eder, Stefan, Henninger, Nicole, El Malki, Khalifa, Lehmann, Nadine, Backes, Nora, Roth, Lea, Seidmann, Larissa, Sommer, Clemens, Brockmann, Marc A., Staatz, Gundula, Schmidberger, Heinz, Faber, Jörg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768397/ https://www.ncbi.nlm.nih.gov/pubmed/29371980 http://dx.doi.org/10.18632/oncotarget.23174 |
Ejemplares similares
-
Activation of the basal cell carcinoma pathway in a patient with CNS HGNET-BCOR diagnosis: consequences for personalized targeted therapy
por: Paret, Claudia, et al.
Publicado: (2016) -
IGF1R Is a Potential New Therapeutic Target for HGNET-BCOR Brain Tumor Patients
por: Vewinger, Nadine, et al.
Publicado: (2019) -
MODL-04. MODELING CNS HGNET-BCOR PATHOGENESIS USING NEURAL STEM CELLS
por: Nakata, Satoshi, et al.
Publicado: (2020) -
Molecular identification of CNS NB-FOXR2, CNS EFT-CIC, CNS HGNET-MN1 and CNS HGNET-BCOR pediatric brain tumors using tumor-specific signature genes
por: Łastowska, Maria, et al.
Publicado: (2020) -
Exploiting Gangliosides for the Therapy of Ewing’s Sarcoma and H3K27M-Mutant Diffuse Midline Glioma
por: Wingerter, Arthur, et al.
Publicado: (2021)